Literature DB >> 11110675

Molecular characterization of a case of atransferrinemia.

E Beutler1, T Gelbart, P Lee, R Trevino, M A Fernandez, V F Fairbanks.   

Abstract

Hereditary atransferrinemia is a rare but instructive disorder that has previously been reported in only 8 patients in 6 families. It is characterized by microcytic anemia and by iron loading, and can be treated effectively by plasma infusions. We now report the first case known in the United States. We determined the sequences flanking the exons of the human transferrin gene and sequenced all of the exons and some of the flanking regions of the patient's DNA and that of her parents. The patient's DNA revealed a 10-base pair (bp) deletion, followed by a 9-bp insertion of a duplicated sequence. There was also a G-->C transversion at complementary DNA (cDNA) nt 1429, predicting that a proline was substituted for the alanine in amino acid position 477 (Ala 477 Pro). The latter mutation occurs at an evolutionarily highly conserved site; 704 control alleles were screened and this point mutation was not found. Each of the patient's transferrin genes contains one mutation, ie, the patient is a compound heterozygote for these mutations, because one was found in each of her parents. In addition to these mutations, which we regard to be causative in the patient's atransferrinemia, a silent polymorphism at cDNA 1572 G-->C was found in exon 13 as well as 2 previously unreported polymorphisms at IVS8 + 62 c-->t and IVS14-4 c-->a. The mutation in nt 1572 and that in intron 8 were common in the general population; the intron 14 mutation is rare.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11110675

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

Review 1.  Known and potential roles of transferrin in iron biology.

Authors:  Thomas Benedict Bartnikas
Journal:  Biometals       Date:  2012-08       Impact factor: 2.949

2.  The G277S transferrin mutation does not affect iron absorption in iron deficient women.

Authors:  Beatriz Sarria; Santiago Navas-Carretero; Ana M Lopez-Parra; Ana M Perez-Granados; Eduardo Arroyo-Pardo; Mark A Roe; Birgit Teucher; M Pilar Vaquero; Susan J Fairweather-Tait
Journal:  Eur J Nutr       Date:  2007-01-05       Impact factor: 5.614

Review 3.  Forging a field: the golden age of iron biology.

Authors:  Nancy C Andrews
Journal:  Blood       Date:  2008-07-15       Impact factor: 22.113

4.  The role of ubiquitination in hepcidin-independent and hepcidin-dependent degradation of ferroportin.

Authors:  Ivana De Domenico; Eric Lo; Baoli Yang; Tamara Korolnek; Iqbal Hamza; Diane McVey Ward; Jerry Kaplan
Journal:  Cell Metab       Date:  2011-10-20       Impact factor: 27.287

Review 5.  Macrophages and iron trafficking at the birth and death of red cells.

Authors:  Tamara Korolnek; Iqbal Hamza
Journal:  Blood       Date:  2015-03-16       Impact factor: 22.113

Review 6.  A systems biology approach to iron metabolism.

Authors:  Julia Chifman; Reinhard Laubenbacher; Suzy V Torti
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 7.  Regulation of iron absorption in hemoglobinopathies.

Authors:  Gideon Rechavi; Stefano Rivella
Journal:  Curr Mol Med       Date:  2008-11       Impact factor: 2.222

Review 8.  Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis.

Authors:  Achille Iolascon; Luigia De Falco; Carole Beaumont
Journal:  Haematologica       Date:  2009-01-30       Impact factor: 9.941

9.  Crosstalk between Iron Metabolism and Erythropoiesis.

Authors:  Huihui Li; Yelena Z Ginzburg
Journal:  Adv Hematol       Date:  2010-06-10

10.  Iron refractory iron deficiency anemia: presentation with hyperferritinemia and response to oral iron therapy.

Authors:  Dong-Anh Khuong-Quang; Jeremy Schwartzentruber; Mark Westerman; Pierre Lepage; Karin E Finberg; Jacek Majewski; Nada Jabado
Journal:  Pediatrics       Date:  2013-01-14       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.